Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat
EFC13738
Phase 3 small_molecule active
Quick answer
Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat, Eliglustat, Cerezyme 400 Units Powder for concentrate for solution for infusion, Eliglustat for Gaucher's disease type I; Gaucher's disease type III is a Phase 3 program (small_molecule) at Genzyme Europe B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genzyme Europe B.V.
- Indication
- Gaucher's disease type I; Gaucher's disease type III
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active